Nasal HIV vaccine adjuvanted with LTK63

· St George's, University of London

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nasal HIV vaccine adjuvanted with LTK63, covering 2008-04-15 to 2008-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study Of Nasal HIV Vaccine Adjuvanted With LTK63 [Phase 1]